“Leadership Vacuum: At NCI Allows NIH To Look At Reorganization, Varmus Says
In Brief: FDA Oncology Div. Director Burke To Leave; Reed Is Branch Chief; NCAB Blasts Tobacco
NCI To Lose 19% of Workforce Over Six Years, Broder Says
NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion
NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes
Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines
Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines
DCPC To Merge Two Programs, Reorganizes Chemoprevention
Trending Stories
- U.S. News & World Report expands evaluation of outcomes in cancer subspecialties
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise - Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies? - FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- Cancer Research Institute announces 2025 recipients of cancer immunotherapy awards